UK Hemostasis Market
Venture Planning Group (VPG), August 2011, Pages: 409
This comprehensive country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the hemostasis diagnostics market during this decade.
The report explores business and technological trend; provides estimates of the test volume, instrument placements and installed base, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next ten years.
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the hemostasis diagnostics practice during the next ten years.
New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Hemostasis testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the hemostasis testing closer to the patient, thus creating additional opportunities and challenges for suppliers.
Each Country Report provides the following information:
- Sales and market shares of major instrument and reagent suppliers.
- Strategic profiles of leading competitors and emerging market entrants.
- Comprehensive market segmentation analysis.
- Forecasts for over 40 procedures, by country and market segment.
- Review of emerging tests.
- Comparison of over 50 automated and semi-automated analyzers.
- Analysis of innovative technologies.
- Estimates of facilities performing hemostasis tests by country.
- Product development and business expansion opportunities.
- Alternative market penetration strategies.
Highlights:
- Comprehensive 409-page analysis of the UK hemostasis market.
- Major issues pertaining to the UK hemostasis laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Ten-year volume and sales forecasts for 40 hemostasis procedures performed in UK hospitals and commercial laboratories, including typical hemostasis daily work loads.
- Placement estimates for major automated and semi-automated systems.
- Review of current instrumentation technologies, and a feature comparison of nearly 50 leading analyzers.
- Ten-year reagent and instrument sales forecasts.
- Sales and market shares of leading reagent and instrument suppliers.
- Review of hemostasis technologies and their potential market applications.
- Major opportunities for hemostasis instruments and consumables.
- Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
- Business opportunities and strategic recommendations for instrument and reagent suppliers.
Contains 409 pages and 16 tables
Methodology
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, and Venture Planning Group's proprietary data files was conducted.
Introduction
Worldwide Market and Technology Overview
A. Major Routine and Special Hemostasis Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests
20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrand's Factor
B. Instrumentation Review
- Introduction
- Benk Hemolab
- Benk TRT Thrombotimer
- Bio/Data MCA 310
- Bio/Data MCA 210
- Bio/Data PAP-4C D/4D/4C
- Cardiovascular Diagnostics COAG
- Diagnostica Stago STA Compact
- Diagnostica Stago STA-R
- Diagnostica Stago Star 4/8
- Helena Laboratories Cascade 480
- Helena Laboratories Cascade M
- Helena Laboratories PACKS-4
- Helena THOR
- Instrumentation Laboratory ACL 100 and 1000 series
- Instrumentation Laboratory ACL6000
- Instrumentation Laboratory ACL7000
- Instrumentation Laboratory ACL9000
- Instrumentation Laboratory Electra 1000C
- Instrumentation Laboratory Electra 1400C
- Instrumentation Laboratory Electra 1600/C
- Instrumentation Laboratory Electra 1800C
- Instrumentation Laboratory Futura
- ITC Hemochron 8000
- Roche Diagnostics CoaguChek
- Siemens BCS
- Siemens BCT
- Siemens BF II/Fibrintimer Series
- Sysmex CA-50
- Sysmex CA-500
- Sysmex CA-1500
- Sysmex CA-5000/CA-1000
- Sysmex CA-6000
- Sysmex CA-7000
- Teco Coatron II/Jr./AccuStasis 5000
- Trinity Biotech Amax CS190
- Trinity Biotech Amax CS400
- Trinity Biotech Coag-A-Mate Max
- Trinity Biotech KC 40, 4A, 1A Series
- Trinity Biotech MDA 180
- Trinity Biotech Coag-A-Mate MTX
- Trinity Biotech Coag-A-Mate RA4
- Trinity Biotech Coag-A-Mate XC/Plus
- Trinity Biotech Coag-A-Mate XM
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
a. Applications
b. Technological Principle
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Dot Immunobinding Assays
- Capillary Immunoassays
- Enzyme Amplification
- Electrochemical Immunoassay
d. Fluorescent Immunoassays
- Fluorescence Polarization
- Time-Resolved Pulse Fluorescence
- Fluorescence Lifetime
e. Latex Agglutination
f. Immunoprecipitation
4. Microcomputers
5. Automation
6. Robotics
7. DNA Probes
a. Overview
b. Amplification Methods
- PCR
- Ligase Chain Reaction
- Branched DNA
- Q-Beta Replicase
- NASBA
- SDA
- 3 SR
- HPA
- Two-Tiered System
- LAT
8. Artificial Intelligence
9. Dry Chemistry
10. Biosensors
D. Worldwide Market Overview
1. Business Environment
2. Market Structure
3. Market Size and Growth
4. POC Testing Market
UK
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers
Major Product Development Opportunities
Design Criteria For Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- American Diagnostica
- Avocet Medical
- Axis-Shield
- Beckman Coulter
- Becton Dickinson
- Bio/Data Corporation
- Biosite
- Chrono-Log
- Corgenix Medical
- Diagnostica Stago
- Helena Laboratories
- HYPEN BioMed
- Instrumentation Laboratory
- ITC
- Nanogen
- Roche
- Siemens
- Sienco
- Sysmex
- Thermo Fischer
- Trinity Biotech
- ZyCare
List of Tables
Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin
Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation
Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator
Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation
Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's
Factor Tests
Worldwide, All Market Segments, Laboratories Performing
Hemostasis Tests By Country, 2010
Worldwide, All Market Segments, Total Hemostasis Test Volume
By Country, 2010-2020
Worldwide, All Market Segments, Total Hemostasis Reagent
Market By Country, 2010-2020
Worldwide, All Market Segments, Total Hemostasis Instrument
Market By Country, 2010-2020
Worldwide, All Market Segments, Total Hemostasis Diagnostics
Market By Country, 2010-2020
Executive Summary Table: U.K., Total Hemostasis Diagnostics
Market By Market Segment and Product Category, 2010-2020
U.K., Laboratories Performing Hemostasis Tests By Market
Segment, 2010
U.K., Hospital Laboratories Performing Hemostasis Tests By
Bed Size, 2010
U.K., Commercial/Private Laboratories Performing Hemostasis
Tests By Annual Test Volume, 2010
U.K., Hospital Laboratories Average Daily Test Volume, 2010
U.K., Commercial/Private Laboratories Average Daily Test
Volume, 2010
U.K., Total Hemostasis Test Volume By Market Segment,
2010-2020
U.K., All Market Segments Hemostasis Test Volume, 2010-2020
U.K., Hospital Laboratories Hemostasis Test Volume, 2010-2020
U.K., Commercial/Private Laboratories Hemostasis Test Volume,
2010-2020
U.K., Hemostasis Reagent Market By Market Segment, 2010-2020
U.K., Major Suppliers of Hemostasis Reagents Estimated Sales
and Market Shares, 2010
U.K., Hemostasis Instrument Market By Market Segment, 2010
U.K., Major Suppliers of Hemostasis Analyzers, Estimated Total
Instrument Placements and Market Shares, 2010
U.K., Major Suppliers of Hemostasis Analyzers, Estimated
Placements and Installed Base By Supplier and Model, 2010
U.K., Major Suppliers of Hemostasis Analyzers, Estimated
Instrument Sales and Market Shares, 2010
U.K., Total Hemostasis Diagnostics Market By Product Category,
2010-2020
U.K., Major Suppliers of Hemostasis Diagnostic Products,
Estimated Sales and Market Shares, 2010
- Abbott
- American Diagnostica
- Avocet Medical
- Axis-Shield
- Beckman Coulter
- Becton Dickinson
- Bio/Data Corporation
- Biosite
- Chrono-Log
- Corgenix Medical
- Diagnostica Stago
- Helena Laboratories
- HYPEN BioMed
- Instrumentation Laboratory
- ITC
- Nanogen
- Roche
- Siemens
- Sienco
- Sysmex
- Thermo Fischer
- Trinity Biotech
- ZyCare
Also available
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
